Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Hydromorphone vs Morphine for Post Cesarean Pain in OUD Patients on Buprenorphine
NCT06784180Phase 4Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2026
- Primary completion
- Jan 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydromorphone in postoperative pain (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Pain score with movement at 12 hours. Planned start Feb 2026; status: withdrawn.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06784180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06784180.